Literature DB >> 8560985

Cytomegalovirus infection of the brain in AIDS: a clinicopathological study.

U Setinek1, E Wondrusch, K Jellinger, A Steuer, M Drlicek, W Grisold, F Lintner.   

Abstract

Based on neuropathological findings, a retrospective case control study of 39 patients with acquired immune deficiency syndrome (AIDS) and confirmed cytomegalovirus (CMV) infection of the brain is presented. Since 1989, the incidence has increased progressively and, in 1994, CMV was the most frequent opportunistic central nervous system (CNS) infection. Of the patients with CMV infections of the brain 16 had one or more coexisting secondary opportunistic and/or tumorous lesions in the CNS. Cerebral involvement by CMV was more frequent in patients with multiple extracerebral organ infections, while 7 among the 39 reported cases showed isolated CMV infection of the brain. The evaluation of the clinical records of 21 patients revealed neuropsychiatric signs and symptoms in 10, while these were absent in 11. All of these patients revealed various types of cerebral lesions related to CMV infection: ventriculitis, focal lesions, and microglial nodule encephalitis. The extent and distribution of cerebral lesions showed no significant correlations with clinical, radiological, or laboratory findings. Further clinicopathological studies are warranted to recognize CMV infections of the CNS and to allow earlier and more efficient treatment of this rather frequent complication of AIDS.

Entities:  

Mesh:

Year:  1995        PMID: 8560985     DOI: 10.1007/bf00294813

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  35 in total

Review 1.  AIDS meningoencephalomyelitis. Pathogenesis and changing neuropathologic findings.

Authors:  R H Rhodes; J M Ward
Journal:  Pathol Annu       Date:  1991

Review 2.  [Pathologic study of the eye and central nervous system in 25 cases of AIDS].

Authors:  U De Girolami; D Hénin; B Girard; C Katlama; P Le Hoang; J J Hauw
Journal:  Rev Neurol (Paris)       Date:  1989       Impact factor: 2.607

3.  Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review.

Authors:  C K Petito; E S Cho; W Lemann; B A Navia; R W Price
Journal:  J Neuropathol Exp Neurol       Date:  1986-11       Impact factor: 3.685

4.  Cytomegalovirus viremia increases with progressive immune deficiency in patients infected with HTLV-III.

Authors:  M Fiala; L A Cone; C M Chang; E S Mocarski
Journal:  AIDS Res       Date:  1986

5.  Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland.

Authors:  W Lang; J Miklossy; J P Deruaz; G P Pizzolato; A Probst; T Schaffner; E Gessaga; P Kleihues
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus.

Authors:  M R Grafe; C A Wiley
Journal:  Ann Neurol       Date:  1989-06       Impact factor: 10.422

Review 7.  Cytomegalovirus and the acquired immunodeficiency syndrome.

Authors:  A S Tyms; D L Taylor; J M Parkin
Journal:  J Antimicrob Chemother       Date:  1989-01       Impact factor: 5.790

8.  [Pathology of the central nervous system in AIDS. An overview of 184 patients].

Authors:  M Drlicek; U Liszka; E Wondrusch; K Jellinger; F Lintner; W Grisold; B Casati
Journal:  Wien Klin Wochenschr       Date:  1993       Impact factor: 1.704

9.  Acquired immunodeficiency syndrome: correlation of radiologic and pathologic findings in the brain.

Authors:  J Balakrishnan; P S Becker; A J Kumar; S J Zinreich; J C McArthur; R N Bryan
Journal:  Radiographics       Date:  1990-03       Impact factor: 5.333

10.  Cytomegalovirus (CMV) encephalomyeloradiculitis and human immunodeficiency virus (HIV) encephalitis: presence of HIV and CMV co-infected multinucleated giant cells.

Authors:  L Bélec; F Gray; J Mikol; F Scaravilli; C Mhiri; A Sobel; J Poirier
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

View more
  8 in total

1.  Inhibitory effects of Ginsenoside Rb1 on apoptosis caused by HSV-1 in human glioma cells.

Authors:  Yuan-Yuan Liang; Bin Wang; Dong-Meng Qian; Ling Li; Zhi-Hao Wang; Ming Hu; Xu-Xia Song
Journal:  Virol Sin       Date:  2012-01-22       Impact factor: 4.327

2.  CD4+ T-cell reconstitution reduces cytomegalovirus in the immunocompromised brain.

Authors:  Jon D Reuter; Jean H Wilson; Kimberly E Idoko; Anthony N van den Pol
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 3.  CNS manifestations of cytomegalovirus infections: diagnosis and treatment.

Authors:  Matthias Maschke; Oliver Kastrup; Hans-Christoph Diener
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain.

Authors:  Jon D Reuter; Daniel L Gomez; Jean H Wilson; Anthony N Van Den Pol
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Neuron-specific activation of murine cytomegalovirus early gene e1 promoter in transgenic mice.

Authors:  Yoshifumi Arai; Mizuho Ishiwata; Satoshi Baba; Hideya Kawasaki; Isao Kosugi; Ren-Yong Li; Takashi Tsuchida; Katsutoshi Miura; Yoshihiro Tsutsui
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

6.  Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.

Authors:  Steven R Wilson; Jean H Wilson; Linda Buonocore; Amy Palin; John K Rose; Jon D Reuter
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

7.  Brain trauma enhances transient cytomegalovirus invasion of the brain only in mice that are immunodeficient.

Authors:  Anthony N van den Pol
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

8.  Cytomegalovirus Infection Associated with Smaller Total Cortical Surface Area in Schizophrenia Spectrum Disorders.

Authors:  Dimitrios Andreou; Kjetil Nordbø Jørgensen; Stener Nerland; Robert H Yolken; Unn K Haukvik; Ole A Andreassen; Ingrid Agartz
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.